Alphamab Oncology (HK:9966)
:9966
Comparison Results
Alphamab Oncology
HK$9.39
HK$9.15B
-76.25
69.23%
1 Buy
0 Hold
0 Sell
Moderate Buy
Ascletis Pharma, Inc.
HK$17.95
HK$19.05B
-9.33
226.49%
2 Buy
1 Hold
0 Sell
Moderate Buy
HBM Holdings Ltd.
HK$12.08
HK$12.61B
5.89
93.57%
1 Buy
0 Hold
0 Sell
Moderate Buy
Abbisko Cayman Limited
HK$13.02
HK$9.01B
135.64
87.41%
3 Buy
0 Hold
0 Sell
Strong Buy
Performance Comparison
HK:9966
Alphamab Oncology
10.78
4.13
62.11%
HK:1672
Ascletis Pharma, Inc.
17.50
11.73
203.29%
HK:2142
HBM Holdings Ltd.
13.84
6.07
78.12%
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.75
1.58
37.89%
HK:2256
Abbisko Cayman Limited
12.80
5.60
77.78%
HK:3681
SinoMab Bioscience Ltd.
1.65
0.50
43.48%